Skip to main content

Table 1 Patient features

From: A prospective cohort study: platelet-rich plasma combined with carpal tunnel release treating carpal tunnel syndrome

 

Control Group

N = 39

PRP Group

N = 43

P-value

Gender

 Male

17(43.6%)

18(41.8%)

0.874

 Female

22 (56.4%)

25(58.2%)

Age

42.5 ± 11.7

41.9 ± 11.7

0.839

BMI

25.6 ± 4.1

25.0 ± 5.1

0.608

Affected side

 Right

20 (51.2%)

26(60.4%)

0.402

 Left

19(48.8%)

17(39.6%)

Symptom duration (month)

24.3 ± 21.7

26.8 ± 23.6

0.613

Grading

 Moderate

26

26

0.560

 Severe

13

17

VAS

4.51 ± 1.27

4.58 ± 1.36

0.817

BCTQ-SSS

2.62 ± 0.51

2.80 ± 0.65

0.189

BCTQ-FSS

2.70 ± 0.68

2.86 ± 0.58

0.250

Grip strength(g/mm2)

16.74 ± 5.36

16.04 ± 5.15

0.556

  1. PRP Platelet-rich plasma, VAS Visual analog scale, BCTQ-SSS Boston carpal tunnel syndrome questionnaire- symptom severity scale, BCTQ-FSS Boston carpal tunnel syndrome questionnaire- functional status scale